trending Market Intelligence /marketintelligence/en/news-insights/trending/XTHxshGhwt4d87IBFn6yZA2 content esgSubNav
In This List

AMS Life Science fiscal Q1 profit falls YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021


AMS Life Science fiscal Q1 profit falls YOY

AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal first quarter ended Nov. 30, 2014, was ¥8.72 per share, a decline of 17.6% from ¥10.58 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥104.1 million, a decrease of 17.1% from ¥125.6 million in the prior-year period.

The normalized profit margin declined to 3.1% from 3.6% in the year-earlier period.

Total revenue fell on an annual basis to ¥3.37 billion from ¥3.46 billion, and total operating expenses decreased from the prior-year period to ¥3.20 billion from ¥3.24 billion.

Reported net income decreased 22.5% from the prior-year period to ¥100.0 million, or ¥8.33 per share, from ¥129.0 million, or ¥10.86 per share.

As of Jan. 14, US$1 was equivalent to ¥116.84.